Page last updated: 2024-10-28

hydrochlorothiazide and Hypokalemic Periodic Paralysis

hydrochlorothiazide has been researched along with Hypokalemic Periodic Paralysis in 1 studies

Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.

Hypokalemic Periodic Paralysis: An autosomal dominant familial disorder characterized by recurrent episodes of skeletal muscle weakness associated with falls in serum potassium levels. The condition usually presents in the first or second decade of life with attacks of trunk and leg paresis during sleep or shortly after awakening. Symptoms may persist for hours to days and generally are precipitated by exercise or a meal high in carbohydrates. (Adams et al., Principles of Neurology, 6th ed, p1483)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Statland, JM1
Fontaine, B1
Hanna, MG1
Johnson, NE1
Kissel, JT1
Sansone, VA1
Shieh, PB1
Tawil, RN1
Trivedi, J1
Cannon, SC1
Griggs, RC1

Reviews

1 review available for hydrochlorothiazide and Hypokalemic Periodic Paralysis

ArticleYear
Review of the Diagnosis and Treatment of Periodic Paralysis.
    Muscle & nerve, 2018, Volume: 57, Issue:4

    Topics: Acetazolamide; Andersen Syndrome; Anti-Arrhythmia Agents; Behavior Therapy; Carbonic Anhydrase Inhib

2018